PharmacoEconomics

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Guidelines for Economic Analysis of Pharmaceutical Products
PharmacoEconomics - Tập 3 - Trang 354-361 - 2012
Allan S. Detsky
Summary In Canada, provincial formulary review committees consider the effectiveness, safety, and cost of products when they derive advice for each Minister of Health. This article offers a draft set of guidelines for pharmaceutical manufacturers making submissions which include economic information, moving beyond a simple presentation of the unit price of the pharmaceutical product (e.g. price pe...... hiện toàn bộ
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models
PharmacoEconomics - - 2017
John Brazier, Roberta Ara, Donna Rowen, Hélène Chevrou‐Séverac
Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure
PharmacoEconomics - Tập 29 - Trang 753-769 - 2012
Alexander Goehler, Benjamin P. Geisler, Jennifer M. Manne, Beate Jahn, Annette Conrads-Frank, G. Scott Gazelle, Uwe Siebert
Chronic heart failure (CHF) is a critical public health issue with increasing effect on the healthcare budgets of developed countries. Various decisionanalytic modelling approaches exist to estimate the cost effectiveness of health technologies for CHF. We sought to systematically identify these models and describe their structures. We performed a systematic literature review in MEDLINE/PreMEDLINE...... hiện toàn bộ
Acknowledgement
PharmacoEconomics - - 2004
NULL AUTHOR_ID
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?
PharmacoEconomics - - 2023
Nancy Devlin, Tianxin Pan, Mark Sculpher, Mark Jit, Elly Stolk, Donna Rowen, Ben van Hout, Richard Norman
Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
PharmacoEconomics - Tập 19 - Trang 767-778 - 2012
Ola Ghatnekar, Ulf Persson, Michael Willis, Knut Ödegaard
Objective: The primary objective of this study was to estimate the cost effectiveness of treating diabetic foot ulcers with becaplermin (Regranex®) plus good wound care (GWC) compared with GWC alone in a variety of European healthcare settings. A secondary objective was to analyse the effect of different treatment practices on the economics of caring for diabetic foot ulcers. ...... hiện toàn bộ
Retrospective Economic and Outcomes Analyses Using Non-US Databases
PharmacoEconomics - - 2007
Lizheng Shi, Eric Q. Wu, Meredith Hodges, Andrew P. Yu, Howard G. Birnbaum
Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era
PharmacoEconomics - Tập 28 - Trang 17-34 - 2012
Mark A. Boyd, Andrew M. Hill
Despite the success of combination antiretroviral therapy (ART) in improving clinical outcomes, treatment failure remains a significant challenge, particularly for highly treatment-experienced patients. This review evaluates current issues in the management of HIV-infected, treatment-experienced patients. It may provide guidance in selecting active, tolerable drug combinations that promote a reaso...... hiện toàn bộ
Healthcare Costs and Obesity Prevention
PharmacoEconomics - Tập 27 - Trang 1031-1044 - 2012
David R. Rappange, Werner B. F. Brouwer, Rudolf T. Hoogenveen, Pieter H. M. Van Baal
Background: Obesity is a major contributor to the overall burden of disease (also reducing life expectancy) and associated with high medical costs due to obesity-related diseases. However, obesity prevention, while reducing obesity-related morbidity and mortality, may not result in overall healthcare cost savings because of additional costs in life-years gained. Sector-specific fi...... hiện toàn bộ
A Review of Health-Related Workplace Productivity Loss Instruments
PharmacoEconomics - Tập 22 Số 3 - Trang 165-184 - 2004
Jennifer H. Lofland, Laura Pizzi, Kevin D. Frick
Tổng số: 2,573   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10